Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal.
作者信息
Shrestha Bhola R, Pandey Deb P, Acharya Krishna P, Thapa-Magar Chhabilal, Mohamed Fahim, Isbister Geoffrey K
机构信息
Curative Service Division, Ministry of Health and Population, Kathmandu, Nepal.
South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
出版信息
Bull World Health Organ. 2017 Oct 1;95(10):718-719. doi: 10.2471/BLT.17.195453. Epub 2017 Aug 1.
Abstract
摘要
相似文献
1
Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal.
Bull World Health Organ. 2017 Oct 1;95(10):718-719. doi: 10.2471/BLT.17.195453. Epub 2017 Aug 1.
2
Krait bite requiring high dose antivenom: a case report.
Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):170-1.
3
Snakebite: sociocultural anthropological bias.
PLoS Med. 2006 Sep;3(9):e412. doi: 10.1371/journal.pmed.0030412.
4
Effectiveness of repeated antivenom therapy for snakebite-related systemic complications.
J Int Med Res. 2019 Oct;47(10):4808-4814. doi: 10.1177/0300060519870012. Epub 2019 Aug 26.
5
Snakebite-reappraisal of the situation in Eastern Nepal.
Toxicon. 2003 Mar 1;41(3):285-9. doi: 10.1016/s0041-0101(02)00289-1.
6
Research strategies to improve snakebite treatment: challenges and progress.
J Proteomics. 2011 Aug 24;74(9):1768-80. doi: 10.1016/j.jprot.2011.06.019. Epub 2011 Jun 25.
7
Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients.
Acad Emerg Med. 2011 Jan;18(1):46-52. doi: 10.1111/j.1553-2712.2010.00958.x. Epub 2010 Dec 16.
8
Specific antivenom for Bungarus candidus.
J Med Assoc Thai. 2007 Jul;90(7):1467-76.
9
Snakebite by the Shore Pit Viper (Trimeresurus purpureomaculatus) Treated With Polyvalent Antivenom.
Wilderness Environ Med. 2016 Jun;27(2):266-70. doi: 10.1016/j.wem.2016.01.001. Epub 2016 Apr 6.
10
Successful use of camelid (alpaca) antivenom to treat a potentially lethal tiger snake (Notechis scutatus) envenomation in a dog.
Toxicon. 2016 May;114:59-64. doi: 10.1016/j.toxicon.2016.02.018. Epub 2016 Feb 27.
引用本文的文献
1
Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review.
Trop Med Infect Dis. 2025 Aug 14;10(8):228. doi: 10.3390/tropicalmed10080228.
2
Cost of Snakebite and Its Impact on Household Economy in Southern Nepal.
Am J Trop Med Hyg. 2024 Nov 19;112(2):431-440. doi: 10.4269/ajtmh.24-0399. Print 2025 Feb 5.
3
Management of snake bite during third trimester of pregnancy with coagulopathy and delivery of a live baby in resource-limited setting in Nepal: a case report.
Oxf Med Case Reports. 2022 Oct 22;2022(10):omac105. doi: 10.1093/omcr/omac105. eCollection 2022 Oct.
4
Access to antivenoms in the developing world: A multidisciplinary analysis.
Toxicon X. 2021 Oct 26;12:100086. doi: 10.1016/j.toxcx.2021.100086. eCollection 2021 Nov.
5
What is the impact of snakebite envenoming on domestic animals? A nation-wide community-based study in Nepal and Cameroon.
Toxicon X. 2021 Jun 5;9-10:100068. doi: 10.1016/j.toxcx.2021.100068. eCollection 2021 Jul.
6
Documentation of a proven Mountain Pitviper () envenomation in Kathmandu, Nepal, with its distribution ranges: implications for prevention and control of pitviper bites in Asia.
J Venom Res. 2021 Jan 6;11:1-6. eCollection 2021.
7
Case Report: Management of Pit Viper Envenoming without Antivenom: A Case Series.
Am J Trop Med Hyg. 2020 Jun;102(6):1440-1442. doi: 10.4269/ajtmh.20-0035.
8
The timing is right to end snakebite deaths in South Asia.
BMJ. 2019 Jan 22;364:k5317. doi: 10.1136/bmj.k5317.
本文引用的文献
1
Development of a new polyspecific antivenom for snakebite envenoming in Sri Lanka: Analysis of its preclinical efficacy as compared to a currently available antivenom.
Toxicon. 2016 Nov;122:152-159. doi: 10.1016/j.toxicon.2016.10.007. Epub 2016 Oct 6.
2
Public perceptions of snakes and snakebite management: implications for conservation and human health in southern Nepal.
J Ethnobiol Ethnomed. 2016 Jun 2;12(1):22. doi: 10.1186/s13002-016-0092-0.
3
Use of Molecular Diagnostic Tools for the Identification of Species Responsible for Snakebite in Nepal: A Pilot Study.
PLoS Negl Trop Dis. 2016 Apr 22;10(4):e0004620. doi: 10.1371/journal.pntd.0004620. eCollection 2016 Apr.
4
A season of snakebite envenomation: presentation patterns, timing of care, anti-venom use, and case fatality rates from a hospital of southcentral Nepal.
J Venom Res. 2016 Jan 23;7:1-9. eCollection 2016.
5
Snake bite: a global failure to act costs thousands of lives each year.
BMJ. 2015 Oct 27;351:h5378. doi: 10.1136/bmj.h5378.
6
A comparative study of venomics of Naja naja from India and Sri Lanka, clinical manifestations and antivenomics of an Indian polyspecific antivenom.
J Proteomics. 2016 Jan 30;132:131-43. doi: 10.1016/j.jprot.2015.10.007. Epub 2015 Oct 24.
7
Antivenom cross neutralisation in a suspected Asian pit viper envenoming causing severe coagulopathy.
Toxicon. 2014 Nov;90:286-90. doi: 10.1016/j.toxicon.2014.08.071. Epub 2014 Aug 30.
8
Awareness and perceptions on prevention, first aid and treatment of snakebites among Sri Lankan farmers: a knowledge practice mismatch?
J Occup Med Toxicol. 2014 May 13;9:20. doi: 10.1186/1745-6673-9-20. eCollection 2014.
9
A hospital based epidemiological study of snakebite in Western Development Region, Nepal.
Toxicon. 2013 Jul;69:98-102. doi: 10.1016/j.toxicon.2013.04.002. Epub 2013 Apr 24.
10
Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
Toxicon. 2013 Jul;69:90-7. doi: 10.1016/j.toxicon.2013.01.022. Epub 2013 Feb 20.
Zotero 插件